This provider's $15.7M in total Medicare payments ranks in the 99th percentile of Ophthalmology providers nationally.
This provider's billing patterns fall within normal ranges for their specialty.
AI-generated analysis based on Medicare payment data.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $941.52 | $319.73 | 2.94x | $621.79 | $2.1M | 15.9K | 7.6K |
| 2015 | $684.02 | $237.02 | 2.89x | $447.00 | $1.7M | 13.7K | 6.3K |
| 2016 | $890.87 | $217.09 | 4.10x | $673.78 | $1.7M | 14.1K | 6.5K |
| 2017 | $783.37 | $217.58 | 3.60x | $565.79 | $1.8M | 14.4K | 6.9K |
| 2018 | $783.57 | $173.28 | 4.52x | $610.29 | $1.6M | 13.7K | 6.4K |
| 2019 | $648.72 | $164.55 | 3.94x | $484.17 | $1.5M | 13.1K | 6.5K |
| 2020 | $844.17 | $198.77 | 4.25x | $645.40 | $1.2M | 9.7K | 5.2K |
| 2021 | $768.90 | $189.13 | 4.07x | $579.77 | $1.4M | 10.6K | 5.3K |
| 2022 | $1.1K | $326.23 | 3.47x | $806.76 | $1.4M | 10.6K | 5.3K |
| 2023 | $720.28 | $259.05 | 2.78x | $461.23 | $1.3M | 10.4K | 5.0K |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| 67210 | Laser destruction of retinal growth, 1 or more sessions | 8.7K | $4.1M | $468.18 | 4.16x |
| J0178 | Injection, aflibercept, 1 mg | 3.7K | $2.8M | $740.59 | 2.02x |
| 92235 | Examination of retinal blood vessels by ophthalmoscope | 19.4K | $2.2M | $111.59 | 3.24x |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | 15.0K | $1.6M | $105.05 | 1.88x |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | 17.2K | $1.3M | $73.43 | 1.96x |
| 92134 | Diagnostic imaging of retina | 31.0K | $1.1M | $35.54 | 3.58x |
| 67028 | Injection of drug into eye | 7.2K | $676.3K | $94.47 | 8.80x |
| 92250 | Photography of the retina | 11.0K | $547.2K | $49.80 | 2.58x |
| 92242 | Imaging of blood vessels in back of eye using fluorescein and indocyanine-green dye | 1.8K | $385.6K | $211.29 | 1.98x |
| 67228 | Laser destruction of leaking retinal blood vessels, 1 or more sessions | 665 | $331.8K | $498.93 | 4.50x |
| 92226 | Examination of eye by ophthalmoscope with retinal drawing | 5.3K | $169.6K | $31.78 | 3.67x |
| J2778 | Injection, ranibizumab, 0.1 mg | 436 | $118.1K | $270.97 | 2.21x |
| J9035 | Injection, bevacizumab, 10 mg | 2.0K | $111.5K | $55.76 | 2.11x |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | 581 | $68.5K | $117.84 | 1.83x |
| 67113 | Repair of detached retina and drainage of eye fluid between lens and retina | 46 | $65.2K | $1.4K | 3.44x |
| J3490 | Unclassified drugs | 31 | $59.1K | $1.9K | 2.31x |
| J3590 | Unclassified biologics | 30 | $54.3K | $1.8K | 2.94x |
| 92240 | Imaging of blood vessels in back of eye using indocyanine-green dye | 189 | $36.0K | $190.25 | 1.79x |
| J0179 | Injection, brolucizumab-dbll, 1 mg | 110 | $27.6K | $250.53 | 1.91x |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | 138 | $21.5K | $155.80 | 2.55x |
This provider submits charges 3.24 times higher than what Medicare actually pays.
A markup ratio of 3.24x means for every $100 Medicare pays, this provider initially charges $324. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Ophthalmology providers in NY for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Jonathan Jonisch, MD | Great Neck, NY | $52.3M | ✓ Clear |
| Jeffrey Josef, M.D. | Suffern, NY | $52.2M | ✓ Clear |
| Brett Rosenblatt | Great Neck, NY | $50.0M | ✓ Clear |
| Kenneth Graham | Great Neck, NY | $47.1M | ✓ Clear |
| Glenn Stoller, M.D. | Rockville Centre, NY | $46.4M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data